Myriad Genetics Inc. (MYGN)
NASDAQ: MYGN
· Real-Time Price · USD
7.20
-0.30 (-4.00%)
At close: Apr 29, 2025, 3:59 PM
7.20
0.00%
After-hours: Apr 29, 2025, 04:11 PM EDT
Myriad Genetics Revenue
Myriad Genetics reported an annual revenue of $753.2M, reflecting a 11.03% growth. For the quarter ending September 30, 2024, Myriad Genetics generated $213.3M in revenue.
Revenue (ttm)
$753.2M
Revenue Growth
11.03%
Price / Sales Ratio
2.1
Revenue / Employee
$278.96K
Employees
2,700
Market Cap
663.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 753.2M | +11.03% |
| Dec 31, 2022 | 678.4M | -1.77% |
| Dec 31, 2021 | 690.6M | +23.99% |
| Dec 31, 2020 | 557M | -34.56% |
| Jun 30, 2020 | 851.1M | n/a |